Isavuconazonium and Midazolam Interaction
Drug interaction information between Isavuconazonium and Midazolam.
Isavuconazonium and Midazolam have a documented moderate interaction in FDA labeling.
FDA drug labeling documents a moderate-severity interaction between Isavuconazonium and Midazolam. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
Isavuconazonium slows down the breakdown of midazolam, which leads to higher levels of the sedative in your blood. This can make the drug's effects much stronger or last longer than intended.
What To Do
Your doctor may need to reduce your dose of midazolam while you are taking these medications together.
FDA Label Information
Midazolam Use with Caution Concomitant administration of CRESEMBA and midazolam results in increase in midazolam exposure. Consider dose reduction of midazolam when isavuconazole is coadministered [see Clinical Pharmacology ( 12.3 )] .
Isavuconazonium Also Interacts With
- Itraconazole major
- Atorvastatin moderate
- Bupropion moderate
- Cyclosporine moderate
- Digoxin moderate
Midazolam Also Interacts With
- Darunavir major
- Itraconazole major
- Nirmatrelvir/Ritonavir major
- Ketoconazole moderate
- Verapamil moderate
Frequently Asked Questions
Can I take Isavuconazonium and Midazolam together?
This is a moderate interaction. Your doctor may need to reduce your dose of midazolam while you are taking these medications together.
How serious is the interaction between Isavuconazonium and Midazolam?
This interaction is classified as "moderate" severity by the FDA. Moderate interactions may worsen your condition or change how your medications work.
Why do Isavuconazonium and Midazolam interact?
Isavuconazonium slows down the breakdown of midazolam, which leads to higher levels of the sedative in your blood. This can make the drug's effects much stronger or last longer than intended.
Understanding the Isavuconazonium and Midazolam Interaction
FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Isavuconazonium belongs to the Azole Antifungal class and Midazolam belongs to the Benzodiazepine class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Isavuconazonium slows down the breakdown of midazolam, which leads to higher levels of the sedative in your blood. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Isavuconazonium has 9 total documented interactions on file in this dataset, and Midazolam has 39. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to reduce your dose of midazolam while you are taking these medications together. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Isavuconazonium or Midazolam based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.